President, Chief Executive Officer and Director · LENZ Therapeutics, Inc. (LENZ)

Josh Lehrer

A named executive officer of LENZ Therapeutics in every fiscal year CompBrief holds from FY2020 to FY2022. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2022

$5,490,535

Salary $550,000Stock awards $0

FY2021: $7,922,159

1st of 3 named executive officers at Lenz Therapeutics by FY2022 total.

3 named officers on file for LENZ Therapeutics, FY2022

Josh Lehrer’s pay file — $29

  • 3 fiscal years of pay, line by line
  • 3 equity grants, each cited to its filing

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how LENZ Therapeutics’s whole pay program stands against its peers

  • LENZ Therapeutics’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on LENZ→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed June 6, 2023 (DEF 14A).

Free

Get Josh Lehrer’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Josh Lehrer compensation by year

LENZ Therapeutics Summary Compensation Table · all 3 fiscal years held
In US dollars, as LENZ Therapeutics reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2020FY2021FY2022
Salary$298,045$464,583$550,000
Bonus$133,880$0$0
Stock awards$23,138$0$0
Option awards$0$7,197,576$4,705,285
Non-equity incentive$0$260,000$233,750
Pension and deferred compensation$0$0$0
All other$0$0$1,500
Total$455,063$7,922,159$5,490,535

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: LENZ Therapeutics, Inc. DEF 14A filed June 6, 2023, accession 0000950170-23-026624, and prior-year filings. Open the filing on EDGAR.

How this page was built: the LENZ Therapeutics, Inc. filed document, accession 0000950170-23-026624. Every figure is read from that document and cited to the page and table it appears in. Filed June 6, 2023.

$455K
$7.9M
$5.5M
FY20
FY21
FY22
SalaryBonusNon-equity incentiveStock awardsOption awardsAll other

Equity holdings

unvested awards at FY2022 year-end
TypeUnvested unitsValue at year-endExercise price
RSU223,466$741,907—
RSU124,671$413,908—
RSU36,378$120,775—
Option447,298—$6.11
Option191,699—$6.11
Option501,042—$11.02

Per the Outstanding Equity Awards at Fiscal Year-End table in LENZ Therapeutics, Inc.'s FY2022 proxy; value at the fiscal year-end close, as the company printed it.

LENZ Therapeutics’s named executive officers, FY2022

as the company reported each
Named executive officerRoleFY2022 total
Josh Lehrer · this pagePresident, Chief Executive Officer and Director$5,490,535
Alethia YoungChief Financial Officer$1,835,489
Philip GutryChief Business Officer$1,382,033

The full LENZ Therapeutics compensation record

free company brief

This page is one person within LENZ Therapeutics's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are LENZ Therapeutics's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Josh Lehrer's compensation dossier · One-time report. No refunds.